Companies /Technology

Cerebras Systems Inc. Class A Common Stock

NASDAQ: CBRS Semiconductors
$104.18
▲ $3.19 (+3.16%) today
Markets closed · 4:44am ET

CBRS at a Glance

Valuation
Market cap
$24.5B
Profitability
Revenue (TTM)
$755.8M
Profit margin
-86.2%
EPS (TTM)
$-5.17
Price
52-week range
$78 – $386
Street target
$210.18

Headquartered in Sunnyvale, CA Fiscal year ends December NASDAQ: CBRS cerebras.ai

About Cerebras Systems

Cerebras Systems builds AI computing infrastructure based on its wafer-scale processors, focused on very fast AI inference. It generates revenue in two ways:
- **Hardware:** direct sales of its CS-series AI systems, with CS-4 nearing full production and CS-5, built on the Wafer Scale Engine 5, targeted for 2027.
- **Cloud and other services:** Cerebras Cloud, its own AI inference cloud backed by contracted data center capacity in North America and Europe.

The company also reaches customers through third-party clouds, including an upcoming integration into Oracle Cloud Infrastructure, deals with hyperscalers and neoclouds, and direct enterprise relationships. Its customers include AI labs, enterprises, research institutes and governments. Cloud services now make up the majority of revenue. The company lists its Master Relationship Agreement with OpenAI among the customer relationships it depends on. Cerebras recently completed its IPO and trades on Nasdaq under CBRS. Updated

Latest Activity

CBRSCerebras Systems
Q3 2026
EPS
-$0.67
est -$0.14-372.2%
Revenue
$211M
est $215M-1.8%

Traders looked past the GAAP loss and bought the guidance: full-year core revenue was raised to $940 million to $960 million. Cloud and services revenue is now outgrowing shrinking hardware sales, a mix shift that defines the story.

Quarterly revenue

CBRS Coverage

Frequently Asked Questions

What does Cerebras Systems do?

Cerebras Systems builds AI computing infrastructure based on its wafer-scale processors, focused on very fast AI inference.

What is the CBRS stock price target?

The Wall Street consensus 12-month price target for CBRS is $210.18.